Karo Pharma publishes the 2021 annual report
HUDDINGE, Sweden, April 12, 2022 /PRNewswire/ -- Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company's website, www.karopharma.com.
The Annual Report is published in Swedish and English. The Swedish version represents the original version and has been translated into English.
This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market Act. The information was submitted for publication on 12 April 2022, at 16:00 CET.
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. We own and commercialize branded, original over-the-counter products and prescription medicines. Our products are available in more than 90 countries, with Europe and the Nordic region as our core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq First North Growth Market.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Annual report 2021 (PDF)
Upcoming Life Sciences Events
- August 2022
- Biotechgate Digital Partnering August 2022
- September 2022
- Redefining Early Stage Investments (RESI)
- BioPharm America™ 2022